SYMPHONY ASSET MANAGEMENT LLC

Holdings History for LIGAND PHARMACEUTICALS INC - NOTE 0.750% 5/1

Investment type: Debt / NOTE 0.750% 5/1

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
30 Jun 2020	5.3%	0%	$15,668,000	18,000,000	0		87.04%	Q2 2020
31 Mar 2020	4.7%	+2.3%	$14,906,000	18,000,000	+9,000,000	+100%	82.81%	Q1 2020
31 Dec 2019	1.7%	+0.48%	$7,790,000	9,000,000	+2,500,000	+38%	86.56%	Q4 2019
30 Sep 2019	1.2%	+1.2%	$5,434,000	6,500,000	+6,500,000	NEW	83.6%	Q3 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.